|
SPCS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.755500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.415080E-04 |
| Normal-vs-Stage2 |
3.816200E-01 |
| Normal-vs-Stage3 |
1.924330E-03 |
| Normal-vs-Stage4 |
9.910100E-02 |
| Stage1-vs-Stage2 |
2.626400E-01 |
| Stage1-vs-Stage3 |
6.921600E-01 |
| Stage1-vs-Stage4 |
8.571400E-01 |
| Stage2-vs-Stage3 |
1.991830E-01 |
| Stage2-vs-Stage4 |
4.116600E-01 |
| Stage3-vs-Stage4 |
9.413600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.593700E-04 |
| Normal-vs-AfricanAmerican |
9.000500E-03 |
| Normal-vs-Asian |
6.909700E-02 |
| Caucasian-vs-AfricanAmerican |
8.292400E-01 |
| Caucasian-vs-Asian |
9.985800E-01 |
| AfricanAmerican-vs-Asian |
9.326800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.79609999999953E-05 |
| Normal-vs-Female |
2.134000E-01 |
| Male-vs-Female |
3.226400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.183500E-02 |
| Normal-vs-Extreme_Weight |
2.443100E-03 |
| Normal-vs-Obese |
2.887900E-02 |
| Normal-vs-Extreme_Obese |
6.243700E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.986400E-01 |
| Normal_Weight-vs-Obese |
6.383400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.750200E-01 |
| Extreme_Weight-vs-Obese |
5.885600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.790000E-01 |
| Obese-vs-Extreme_Obese |
2.546000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.873800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.248000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.030350E-04 |
| Normal-vs-Age(81-100Yrs) |
1.216480E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.808200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.651400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.164570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.983500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.194780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.343800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.617000E-03 |
| Normal-VS-Type2 PRCC |
3.21969999994565E-06 |
| Normal-VS-KIRP CIMP |
4.112600E-01 |
| Normal-VS-Unclassified PRCC |
1.512780E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.284100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.674000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.791800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.470190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.433600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.719800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.154340E-04 |
| Normal-vs-N1 |
1.879980E-02 |
| Normal-vs-N2 |
8.648800E-01 |
| N0-vs-N1 |
6.515800E-01 |
| N0-vs-N2 |
2.517200E-01 |
| N1-vs-N2 |
4.088200E-01 |
|
|
